We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+0.05%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.55B
AUM Growth
+$59.4M
Cap. Flow
-$31.8M
Cap. Flow %
-0.9%
Top 10 Hldgs %
49.57%
Holding
665
New
156
Increased
155
Reduced
111
Closed
128
Avg Time Held Equity + Options
3.9 quarters
Top 10 Avg Time Held Equity + Options
0.8 quarters
Top 20 Avg Time Held Equity + Options
1.2 quarters
Avg Time Held Equity only
4.3 quarters
Top 10 Avg Time Held Equity only
0.8 quarters
Top 20 Avg Time Held Equity only
1.2 quarters

Top Buys

Rank Stock Value
1
HCP icon
HashiCorp, Inc. Class A Common Stock
HCP
+$138M
2
ETRN icon
Equitrans Midstream Corporation Common Stock
ETRN
+$131M
3
EDR icon
Endeavor Group Holdings, Inc.
EDR
+$127M
4
MRO icon
Marathon Oil Corporation
MRO
+$123M
5
CHX icon
ChampionX
CHX
+$98.3M

Top Sells

Rank Stock Value
1
PXD icon
Pioneer Natural Resource Co.
PXD
+$638M
2
CERE icon
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$51.2M
3
DFS icon
Discover Financial Services
DFS
+$45.1M
4
SCRM icon
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
+$18.4M
5
NSC icon
Norfolk Southern
NSC
+$17.7M

Sector Composition

Rank Sector Weight
1 Energy 26.53%
2 Technology 21.03%
3 Healthcare 14.68%
4 Industrials 8.19%
5 Miscellaneous 6.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
MRNA icon
401
PUT
Moderna
MRNA
$89.8B
$237K 0.01%
+28,000
New +$3.54M
2024 Q2
0 quarters
SPY icon
402
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$833B
$227K 0.01%
+100,000
New +$52.3M
2024 Q2
0 quarters
OVID icon
403
Ovid Therapeutics
OVID
$480M
$222K 0.01%
288,290
+28,790
+11% +$80.1K
2023 Q2
4 quarters
QTTB icon
404
Q32 Bio
QTTB
$248M
$215K 0.01%
+12,000
New +$287K
2024 Q2
0 quarters
NFE icon
405
PUT
New Fortress Energy
NFE
$24.9M
$187K 0.01%
+1,022
New +$1.32M
2024 Q2
0 quarters
NBR icon
406
PUT
Nabors Industries
NBR
$1.23B
$185K 0.01%
19,100
– –
2024 Q1
1 quarter
HOG icon
407
PUT
Harley-Davidson
HOG
$2.8B
$178K 0.01%
100,000
– –
2023 Q3
3 quarters
SVRA icon
408
Savara
SVRA
$1.01B
$177K 0.01%
43,978
-43,459
-50% -$193K
2022 Q2
8 quarters
XME icon
409
PUT
State Street SPDR S&P Metals & Mining ETF
XME
$4.22B
$152K ﹤0.01%
+104,900
New +$6.42M
2024 Q2
0 quarters
OMF icon
410
PUT
OneMain Financial
OMF
$6.45B
$132K ﹤0.01%
30,500
– –
2022 Q3
7 quarters
VRDN icon
411
Viridian Therapeutics
VRDN
$2.11B
$131K ﹤0.01%
10,057
-6,400
-39% -$88.6K
2022 Q1
9 quarters
IMUX icon
412
Immunic
IMUX
$112M
$131K ﹤0.01%
11,769
-5,000
-30% -$62.1K
2022 Q1
9 quarters
SYF icon
413
PUT
Synchrony
SYF
$23.7B
$124K ﹤0.01%
+21,900
New +$951K
2024 Q2
0 quarters
EVLVW icon
414
DELISTED
Evolv Technologies Warrant
EVLVW
$122K ﹤0.01%
478,241
– –
2021 Q3
11 quarters
DTIL icon
415
Precision BioSciences
DTIL
$185M
$112K ﹤0.01%
11,546
– –
2022 Q2
8 quarters
CCL icon
416
PUT
Carnival Corporation Ltd
CCL
$35.4B
$107K ﹤0.01%
771,500
– –
2021 Q3
11 quarters
VNO icon
417
PUT
Vornado Realty Trust
VNO
$6.28B
$107K ﹤0.01%
+33,500
New +$857K
2024 Q2
0 quarters
FE icon
418
PUT
FirstEnergy
FE
$26B
$105K ﹤0.01%
+26,000
New +$1.01M
2024 Q2
0 quarters
VKTX icon
419
CALL
Viking Therapeutics
VKTX
$3.63B
$102K ﹤0.01%
13,600
-36,400
-73% -$2.39M
2024 Q1
1 quarter
IONS icon
420
CALL
Ionis Pharmaceuticals
IONS
$7.52B
$98.1K ﹤0.01%
18,000
-2,000
-10% -$82K
2024 Q1
1 quarter
UBX icon
421
DELISTED
Unity Biotechnology
UBX
$97.2K ﹤0.01%
71,983
+1,586
+2% +$2.41K
2022 Q3
7 quarters
IMCR icon
422
PUT
Immunocore
IMCR
$1.51B
$94.5K ﹤0.01%
+30,000
New +$1.53M
2024 Q2
0 quarters
NVO icon
423
CALL
Novo Nordisk
NVO
$171B
$90.1K ﹤0.01%
35,000
-10,000
-22% -$1.33M
2024 Q1
1 quarter
CCOI icon
424
PUT
Cogent Communications
CCOI
$437M
$90K ﹤0.01%
+17,300
New +$1.03M
2024 Q2
0 quarters
CYH icon
425
CALL
Community Health Systems
CYH
$389M
$88.1K ﹤0.01%
525,000
– –
2024 Q1
1 quarter
15 16
17
18 19

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q2 2024 Portfolio in Review

As of Q2 2024, UBS O'Connor held 665 positions worth $3.55B, up 1.7% from $3.49B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

UBS O'Connor's Q2 2024 filing shows 156 new, 155 increased, 111 reduced and 128 closed positions. Its largest new stake was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M. The largest sale was Pioneer Natural Resource Co., an estimated $638M.

By sector, the portfolio is most concentrated in Energy at 27% of assets, down from 34% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q2 2024 buy was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M.
  • UBS O'Connor added most to HashiCorp, Inc. Class A Common Stock in Q2 2024, an estimated $138M increase.
  • UBS O'Connor's biggest Q2 2024 reduction was Cerevel Therapeutics Holdings, Inc. Common Stock, cutting an estimated $51.2M.
  • UBS O'Connor fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $638M.
  • UBS O'Connor's ten largest holdings make up 50% of its $3.55B portfolio in Q2 2024.
  • UBS O'Connor opened 156 new positions and closed 128 in Q2 2024.
  • UBS O'Connor's portfolio value rose 1.7% quarter-over-quarter to $3.55B.

Based on UBS O'Connor's 13F filing for Q2 2024, filed 14 Aug 2024.